Antimicrobial susceptibility testing with EUCAST methods and breakpoints
Friday, July 9, 2021
3. Bacterial susceptibility & resistance, 2,5-hour Educational Workshop
3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB)
•
2166
•
8:30 AM
>
11:00 AM
•
Antimicrobial susceptibility testing with EUCAST methods and breakpoints
•
3. Antimicrobial resistance
3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB)
8:30 AM
•
2166-1
•
EUCAST Update
>
C.
Christian
GISKE (Stockholm)
8:45 AM
•
2166-2
•
Susceptible: increased exposure and area of technical uncertainty: the story so far
>
G.
Gunnar
KAHLMETER (Växjö)
9:00 AM
•
2166-3
•
Aminoglycosides revisited
>
S.
Shampa
DAS (Liverpool)
9:15 AM
•
2166-4
•
Piperacillin-tazobactam breakpoints in the wake of the Merino trial
>
A.
Alasdair
MACGOWAN (Bristol)
9:30 AM
•
2166-5
•
Breakpoints for meningitis
>
C.
Christian
GISKE (Stockholm)
9:45 AM
•
2166-6
•
Advances in mycobacterial AST
>
E.
Emmanuelle
CAMBAU (Paris)
10:00 AM
•
2166-7
•
Antifungal susceptibility testing: update
>
M.
Maiken Cavling
ARENDRUP (Copenhagen)
10:15 AM
•
2166-8
•
AST of <em>Stenotrophomonas</em> and <em>Burkholderia</em>
>
M.
Mandy
WOOTTON (Cardiff)
10:30 AM
•
2166-9
•
Q&A/Discussion
|